{"id":"W3134910506","doi":"10.1200/jco.2021.39.6_suppl.239","title":"Safety of darolutamide (DARO) for nonmetastatic castration-resistant prostate cancer (nmCRPC) from extended follow-up in the phase III ARAMIS trial.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Placebo; Incidence (geometry); Internal medicine; Rash","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003473971,0.0008901627,0.001568404,0.0003345907,0.0003356153,0.00110079,0.0006598542,0.001045661,0.003382385],"category_scores_gemma":[0.002006258,0.0002918338,0.00251591,0.0003221781,0.0004830946,0.0008448992,0.0003998905,0.002597443,0.0006227582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005878057,"about_ca_system_score_gemma":0.0008967782,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003401773,"about_ca_topic_score_gemma":0.001159599,"domain_scores_codex":[0.9990234,0.0005929206,0.0000470356,0.0001129924,0.0001042652,0.0001194423],"domain_scores_gemma":[0.9985013,0.0003922039,0.0004398358,0.0001373683,0.00007441561,0.0004548777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8802829,0.004627462,0.008193709,0.001029572,0.002631982,0.0001864579,0.0001186843,0.001462481,0.008576524,0.0002569995,0.003052702,0.08958062],"study_design_scores_gemma":[0.6884115,0.2380116,0.05505563,0.0002002751,0.003060422,0.0007854789,0.00006439455,0.003047855,0.003341319,0.0008881758,0.007063663,0.00006971335],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774415,0.01391036,0.0009613642,0.0005466557,0.0002298481,0.0009799908,0.002989847,0.0001328971,0.002807536],"genre_scores_gemma":[0.9900502,0.002668416,0.0009536284,0.0005314734,0.0002360746,0.0007533638,0.003542535,0.00002163861,0.0012427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003473971,"threshold_uncertainty_score":0.0183723,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1805793952263794,"score_gpt":0.5243375010670506,"score_spread":0.3437581058406711,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}